Last edition
News about "Phase 1 clinical trial "
MetaVia Advances Obesity Drug Development with First Patient Dosed in DA-1726 Phase I Trial
MetaVia initiates Part 3 of its phase I trial for DA-1726, evaluating higher-dose strategies to enhance weight loss, metabolic outcomes and tolerability in obesity and cardiometabolic disease treatment.
Phase 1 Clinical Trial | 13/04/2026 | By News Bureau
Phrontline Biopharma Announces First Patient Dosed in Phase-I Clinical Trial of TJ101
The Phase 1 study of TJ101 will assess its safety, tolerability, pharmacokinetics, and early anti-tumor activity in various solid tumors, using a dose escalation and expansion cohort design.
Phase 1 Clinical Trial | 15/09/2025 | By Dineshwori | 108
Inventiva and Hepalys Pharma Initiate Clinical Development Program of Lanifibranor in Japan
The trial is conducted pursuant to the terms of the exclusive licensing agreement entered into in 2023 between Inventiva and Hepalys to develop and commercialize lanifibranor in Japan and South Korea.
Phase 1 Clinical Trial | 21/02/2025 | By Aishwarya | 607
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy